We are focused on delivering PRECISION with our multi-disciplinary EXPERTISE because we are committed to deliver quality liver cancer treatment you deserve.
.jpg)
What is Liver SBRT?
Liver SBRT, or Stereotactic Body Radiation Therapy, is a highly precise form of radiation therapy used to treat liver tumors. It involves delivering high doses of radiation to the tumor site while minimizing exposure to surrounding healthy tissue.
Liver SBRT is important because it offers a non-invasive treatment option with high precision, reducing damage to healthy liver tissue and surrounding organs. It is especially valuable for patients who are not candidates for surgery.
Click on any of the button below to read more on the relevant details of Liver SBRT:
Non-Surgical Liver Directed Therapies
Non-Surgical Liver Directed Therapies is a specialized approach to managing liver cancer, providing targeted treatment options without the need for surgery. Our team of experts, including hepatologists, oncologists, and a multidisciplinary team, collaborates closely to develop personalized treatment plans for each patient. By focusing on the unique stages of the disease, we strive to optimize outcomes and improve quality of life.
With a range of therapies available, such as radiation therapy, chemoembolization, and ablation techniques, we offer hope and specialized attention to individuals diagnosed with liver cancer.
Meet Our Liver Specialists
Dr David Tan Boon Harn
MEDICAL DIRECTOR (AARO)
SENIOR CONSULTANT RADIATION ONCOLOGIST
MBBS (SIN), FRCR (CLINICAL ONCOLOGY, UK), FAMS (RADIATION ONCOLOGY)
View Dr David's profile here
Dr Daniel Tan Yat Harn
DIRECTOR
SENIOR CONSULTANT RADIATION ONCOLOGIST
MBBS (SIN), FRCR (CLINICAL ONCOLOGY, UK), FAMS (RADIATION ONCOLOGY),
MBA (Healthcare Management)
View Dr Daniel's profile here
Dr Jonathan Teh Yi Hui
MEDICAL DIRECTOR (CSR)
SENIOR CONSULTANT RADIATION ONCOLOGIST
MBBS (SIN), FRCR (CLINICAL ONCOLOGY, UK), FAMS (RADIATION ONCOLOGY)
View Dr Jonathan's profile here
Our Insurance Panel
-
What are the results of SBRT to the liver?Results of SBRT in treating both primary and secondary liver tumours are promising, showing better results in controlling these tumours compared to historical conventional radiation therapy given daily over few weeks. One study* of 102 patients with hepatocellular carcinoma (HCC), the most common primary liver cancer, showed that at 1-year post SBRT, 87% of patients still had the tumour under control. Of note, more than half of these patients had tumour within the large veins of the liver, which often limits effective treatment options. For secondary liver tumours, the possibility of local control with SBRT is also excellent at 70-100% at 1 year and 60-90% at 2 years.** *Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma. Bujold et al. Journal of Clinical Oncology 31, no. 13 (May 2013) 1631-1639 ** Radiotherapy for Liver Metastases: A Review of Evidence. Hoyer et al. International Journal of Radiation Oncology Biology Physics. March 1, 2012 Volume 82, Issue 3, Pages 1047–1057
-
What are the side effects of SBRT to the liver?The early side effects of SBRT to the liver include fatigue, nausea (rarely vomiting) and mild skin changes. These are temporary and resolve within a month of radiation therapy. The normal liver cells can be damaged by radiotherapy, with the effects seen only a few weeks after SBRT. With attention to technique in avoiding as much normal liver as possible, this usually shows up as mild to moderate abnormalities in the liver blood tests without any symptoms. The blood tests tend to normalise with time. For patients with underlying unhealthy liver, there is a higher risk of having radiation-induced liver disease that is severe enough to cause liver failure. Patient selection is therefore very important.
-
How can I know if I will benefit from SBRT to the liver?SBRT to the liver is not for all patients with liver tumours. Sometimes surgery or chemotherapy may be more suitable. Even when radiotherapy is the preferred option, the tumor may be too close to critical organs or the liver too unhealthy for high dose SBRT to be performed, in which case lower doses of conventional radiotherapy may have to be used. It is therefore vital that all patients considering liver SBRT be assessed by a radiation oncologist with experience and expertise in liver SBRT, before embarking on this advanced treatment.